ALK and non-small cell lung carcinoma: Opto-dALK was inactive in ALK degradation; however, with UV irradiation, a light- and drug dose-dependent EML-ALK degradation was observed (NCI-H2228 or NCI-3122 non-small cell lung cancer cell lines).